Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
In- or outpatients with schizophrenia, 18-65 years old, requiring a change in treatment due to insufficient efficacy or tolerability and giving signed informed consent.
You may not be if
Known diabetes mellitus, high HbA1c, fasting plasma glucose and/or high 2h glucose-OGTT.
Previous use of atypicals (3 months) or other medications that might influence glucose metabolism
Contraindications or non-responsiveness for any of the treatments or other safety issues
Expected non-compliance to treatment and/or study procedures